NAD, ATP and lipid contents in normal and leukemic human leukocytes, before and after cytostatic therapy.
D000255:Adenosine Triphosphate / Q000097:blood*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005227:Fatty Acids / Q000097:blood; D006019:Glycolysis; D006801:Humans; D007094:Imides / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000097:blood; D007951:Leukemia, Myeloid / Q000097:blood* / Q000139:chemically induced / Q000188:drug therapy; D007962:Leukocytes / Q000187:drug effects / Q000378:metabolism*; D008055:Lipids / Q000097:blood*; D008748:Methylcholanthrene; D009243:NAD / Q000097:blood*; D009368:Neoplasm Transplantation; D010743:Phospholipids / Q000097:blood; D051381:Rats; D013997:Time Factors; D014508:Urea / Q000627:therapeutic use
D000970:Antineoplastic Agents; D005227:Fatty Acids; D007094:Imides; D008055:Lipids; D010743:Phospholipids; D009243:NAD; D008748:Methylcholanthrene; D000255:Adenosine Triphosphate; D003520:Cyclophosphamide; D014508:Urea; D002784:Cholesterol; D002066:Busulfan